Psoriatic Immune Response to Tildrakizumab

Clinical trial NCT05390515 · RECRUITING

Trial details

NCT number: NCT05390515
Sponsor: University of California, San Francisco
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 2022-09-01
Primary completion: 2028-09-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.